Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on IBAT Inhibitor. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN1284953A details a novel cyclization process for IBAT inhibitors, offering high stereoselectivity and scalable manufacturing for pharmaceutical intermediates.
Patent CN1106395C details a novel asymmetric synthesis for IBAT inhibitor intermediates, offering superior stereocontrol and scalable manufacturing for pharmaceutical supply chains.